제약바이오강국을 선도하는 산업인재양성
성균관대학교 제약산업특성화대학원

연구과제







2016Cost-effectiveness analysis of palbociclib for the treatment of ER+/HER2- advanced/metastatic breast cancer / 이의경

Cost-effectiveness analysis of palbociclib for the treatment of ER+/HER2- advanced/metastatic breast cancer